ListarArtículos (Instituto de Biomedicina de Sevilla (IBIS)) por materia "Ruxolitinib"
Mostrando ítems 1-1 de 1
-
Artículo
Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
(BioMed Central, 2017)Background: Ruxolitinib is a potent inhibitor of JAK1/2 with proven efcacy in myelofbrosis. In recent years, research in ...